Key facts
- This page summarizes Yingjuan June Lu's Form 3 filing for BeyondSpring Inc. (BYSI).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 31 Dec 2024, 13:34.
Yingjuan June Lu - 31 Dec 2024 Form 3 Insider Report for BeyondSpring Inc. (BYSI)
- Reporting relationship
- Chief Scientific Officer
- Issuer ticker
- BYSI
- Reported as of
- 31 Dec 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 31 Dec 2024, 13:34:04 UTC
- Next SEC filing
- 23 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Yingjuan June Lu
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Yingjuan June Lu filed Form 3 for BeyondSpring Inc. (BYSI) on 31 Dec 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BYSI
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100
- Date
- 31 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BYSI
holding
Derivative
Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 10,000
- Exercise price
- $16.55
- Footnotes
- F1
BYSI
holding
Derivative
Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,003
- Exercise price
- $4.26
- Footnotes
- F2
BYSI
holding
Derivative
Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 5,000
- Exercise price
- $0.9000
- Footnotes
- F3
BYSI
holding
Derivative
Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 19,180
- Exercise price
- $1.33
- Footnotes
- F4
BYSI
holding
Derivative
Stock Options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- $3.57
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 7,500 of the stock options are fully vested and exercisable. 2,500 of the stock options will vest on October 18, 2025.
Footnote F2
Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. All 2,003 stock options are fully vested and exercisable.
Footnote F3
Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 3,333 of the stock options are fully vested and exercisable. 1,667 of the stock options will vest on December 31, 2024.
Footnote F4
Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Incentive Plan. 6,393 of the stock options are fully vested and exercisable. 6,393 of the stock options will vest on December 31, 2024, and 6,394 of the stock options will vest on June 30, 2025.
Footnote F5
Reflects the grant of stock options to purchase ordinary shares of the Issuer under the 2017 Omnibus Inventive Plan. None of the stock options have become fully vested and exercisable. The stock options will vest in equal 25% installments on the first, second, third and fourth anniversaries of April 1, 2024.
SEC remarks
As the Company no longer qualifies as a foreign private issuer, effective January 1, 2025, the Company's officers, directors, and principal shareholders are subject to Section 16 of the Securities Exchange Act of 1934 ("Exchange Act"). Previously, the Company determined that it qualified as a foreign private issuer under the Exchange Act.